Cocrystal Pharma, Inc. (COCP) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Cocrystal Pharma, Inc. (COCP) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $9.8M, listed on NASDAQ, employing roughly 10 people, carrying a beta of 1.41 to the broader market. Cocrystal Pharma, Inc. Led by James E. Sapirstein, public since 2012-02-22.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for COCP as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →